Filing Details

Accession Number:
0001179110-11-005196
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-03-17 19:45:27
Reporting Period:
2011-03-15
Filing Date:
2011-03-17
Accepted Time:
2011-03-17 19:45:27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1145460 Alere Inc. ALR In Vitro & In Vivo Diagnostic Substances (2835) 043565120
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1208157 T Paul Hempel 51 Sawyer Road, Suite 200
Waltham MA 02453
Svp Ethics & Compliance No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-03-15 25,856 $15.47 36,259 No 4 M Direct
Common Stock Disposition 2011-03-15 6,175 $36.76 30,084 No 4 S Direct
Common Stock Disposition 2011-03-15 13,034 $36.75 17,050 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (Right to Buy) Disposition 2011-03-15 25,856 $0.00 25,856 $15.47
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2005-11-30 2011-11-30 No 4 M Direct
Footnotes
  1. This derivative security does not have a price.
  2. These options became exercisable in four equal annual installments beginning 11/30/2002.
  3. Transactions represent "sell to cover" exercise of stock options.